Denmark· DK-28107106824
LYNOZYFIC
A linvoseltamab product containing linvoseltamab, registered in Denmark by Regeneron Ireland Designated Activity Company. The same ATC class is registered in 3 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Linvoseltamab is registered in 3 of 19 countries.
Countries holding a registration under ATC L01FX37 (linvoseltamab), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 2 of them publish a price we can compare per daily dose
Linvoseltamab · ATC L01FX37
3 / 19 countries
- Czechiaprice
- Denmark
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- linvoseltamab
- Manufacturer
- Regeneron Ireland Designated Activity Company
- Country
- Denmark (DK)
- ATC code
- L01FX37
- ATC class
- Linvoseltamab
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107106824
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01FX37
Linvoseltamab, as other registers publish it.
- CzechiaLYNOZYFICRegeneron Ireland Designated Activity Company, Dublin
- United StatesLYNOZYFICRegeneron Pharmaceuticals, Inc.
- CzechiaLYNOZYFICRegeneron Ireland Designated Activity Company, Dublin
- DenmarkLYNOZYFICRegeneron Ireland Designated Activity Company
- United StatesLYNOZYFICRegeneron Pharmaceuticals, Inc.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/77ad8315-5f0b-4f90-9dcc-07f0f517f898 GET /v1/drugs/77ad8315-5f0b-4f90-9dcc-07f0f517f898?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "200 mg",
"auth_role": "MOD",
"dk_drugid": "28107106824",
"substance": "linvoseltamab",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "45770"
}See everything about linvoseltamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.